Practical considerations for the implementation of adaptive designs for oncology Phase I dose-finding trials
{{output}}
The traditional 3 + 3 design continues to be commonly used for Phase I dose-finding oncology trials, despite increasing criticisms and development of innovative methods. Unfortunately, it is a challenge to convince principal investigators to use novel designs.... ...
